Noninvasive Cancer Diagnostics Market Report

China Noninvasive Cancer Diagnostics Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：213
  • REPORT CODE：GMM1821558
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Noninvasive Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Precision Therapeutics, Inc (US)

    • Affymetrix Inc (US)

    • AandG Pharmaceutical, Inc (US)

    • Gen-Probe Incorporated (US)

    • IVDiagnostics, Inc (US)

    • Digene Corporation (US)

    • AVIVA Biosciences Corporation (US)

    • Laboratory Corporation of America Holdings (LabCorp) (US)

    • BIOVIEW Inc (US)

    By Type:

    • Molecular Diagnostics

    • Clinical Chemistry

    • Immunochemistry/Immunoassay

    • Others

    By Application:

    • Lung Cancer

    • Others

    • Solid Tumors

    • Blood Cancer

    • Breast Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Noninvasive Cancer Diagnostics Market Overview 2018-2029

    • 1.1 China Noninvasive Cancer Diagnostics Industry Development Overview

    • 1.2 China Noninvasive Cancer Diagnostics Industry Development History

    • 1.3 China Noninvasive Cancer Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Noninvasive Cancer Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

      • 1.4.2 China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Clinical Chemistry (2018-2029)

      • 1.4.3 China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Immunochemistry/Immunoassay (2018-2029)

      • 1.4.4 China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Noninvasive Cancer Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.2 China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

      • 1.5.4 China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

      • 1.5.5 China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • 1.6 China Noninvasive Cancer Diagnostics Market Analysis by Region

      • 1.6.1 North China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Noninvasive Cancer Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Noninvasive Cancer Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Noninvasive Cancer Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Noninvasive Cancer Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Noninvasive Cancer Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Noninvasive Cancer Diagnostics Industry Development

    Chapter 3 Noninvasive Cancer DiagnosticsIndustry Chain Analysis

    • 3.1 Noninvasive Cancer Diagnostics Industry Chain

    • 3.2 Noninvasive Cancer Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Noninvasive Cancer Diagnostics Market

    • 3.3 Noninvasive Cancer Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Noninvasive Cancer Diagnostics Market

    Chapter 4 China Noninvasive Cancer Diagnostics Market, by Type

    • 4.1 China Noninvasive Cancer Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Noninvasive Cancer Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Noninvasive Cancer Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Molecular Diagnostics

      • 4.5.2 China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Clinical Chemistry

      • 4.5.3 China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Immunochemistry/Immunoassay

      • 4.5.4 China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Others

    Chapter 5 China Noninvasive Cancer Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Noninvasive Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Noninvasive Cancer Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Lung Cancer

      • 5.5.2 China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Others

      • 5.5.3 China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Solid Tumors

      • 5.5.4 China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Blood Cancer

      • 5.5.5 China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Breast Cancer

    Chapter 6 China Noninvasive Cancer Diagnostics Market, by Region

    • 6.1 China Noninvasive Cancer Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Noninvasive Cancer Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Noninvasive Cancer Diagnostics Market Analysis

    • 7.1 North China Noninvasive Cancer Diagnostics Market, by Type

    • 7.2 North China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 8 Central China Noninvasive Cancer Diagnostics Market Analysis

    • 8.1 Central China Noninvasive Cancer Diagnostics Market, by Type

    • 8.2 Central China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 9 South China Noninvasive Cancer Diagnostics Market Analysis

    • 9.1 South China Noninvasive Cancer Diagnostics Market, by Type

    • 9.2 South China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 10 East China Noninvasive Cancer Diagnostics Market Analysis

    • 10.1 East China Noninvasive Cancer Diagnostics Market, by Type

    • 10.2 East China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 11 Northeast China Noninvasive Cancer Diagnostics Market Analysis

    • 11.1 Northeast China Noninvasive Cancer Diagnostics Market, by Type

    • 11.2 Northeast China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 12 Southwest China Noninvasive Cancer Diagnostics Market Analysis

    • 12.1 Southwest China Noninvasive Cancer Diagnostics Market, by Type

    • 12.2 Southwest China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 13 Northwest China Noninvasive Cancer Diagnostics Market Analysis

    • 13.1 Northwest China Noninvasive Cancer Diagnostics Market, by Type

    • 13.2 Northwest China Noninvasive Cancer Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Precision Therapeutics, Inc (US)

        • 14.1.1 Precision Therapeutics, Inc (US) Company Profile

        • 14.1.2 Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Affymetrix Inc (US)

        • 14.2.1 Affymetrix Inc (US) Company Profile

        • 14.2.2 Affymetrix Inc (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AandG Pharmaceutical, Inc (US)

        • 14.3.1 AandG Pharmaceutical, Inc (US) Company Profile

        • 14.3.2 AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Gen-Probe Incorporated (US)

        • 14.4.1 Gen-Probe Incorporated (US) Company Profile

        • 14.4.2 Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 IVDiagnostics, Inc (US)

        • 14.5.1 IVDiagnostics, Inc (US) Company Profile

        • 14.5.2 IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Digene Corporation (US)

        • 14.6.1 Digene Corporation (US) Company Profile

        • 14.6.2 Digene Corporation (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 AVIVA Biosciences Corporation (US)

        • 14.7.1 AVIVA Biosciences Corporation (US) Company Profile

        • 14.7.2 AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Laboratory Corporation of America Holdings (LabCorp) (US)

        • 14.8.1 Laboratory Corporation of America Holdings (LabCorp) (US) Company Profile

        • 14.8.2 Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 BIOVIEW Inc (US)

        • 14.9.1 BIOVIEW Inc (US) Company Profile

        • 14.9.2 BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Noninvasive Cancer Diagnostics Industry Research Conclusions

    • 15.2 Noninvasive Cancer Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Noninvasive Cancer Diagnostics Industry Market Size (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Clinical Chemistry (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Immunochemistry/Immunoassay (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure North China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Noninvasive Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Noninvasive Cancer Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Noninvasive Cancer Diagnostics Market Share by Type in 2018

    • Figure China Noninvasive Cancer Diagnostics Market Share by Type in 2023

    • Figure China Noninvasive Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Molecular Diagnostics (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Clinical Chemistry (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Immunochemistry/Immunoassay (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Market Share by Application in 2018

    • Figure China Noninvasive Cancer Diagnostics Market Share by Application in 2023

    • Figure China Noninvasive Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Solid Tumors (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Production Volume by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Production Value by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Sales Volume by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Sales Value by Region (2018-2023)

    • Table China Noninvasive Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Noninvasive Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table North China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table South China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table East China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Noninvasive Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Noninvasive Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Noninvasive Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Noninvasive Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Precision Therapeutics, Inc (US) Company Profile

    • Table Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Affymetrix Inc (US) Company Profile

    • Table Affymetrix Inc (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table AandG Pharmaceutical, Inc (US) Company Profile

    • Table AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Gen-Probe Incorporated (US) Company Profile

    • Table Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table IVDiagnostics, Inc (US) Company Profile

    • Table IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Digene Corporation (US) Company Profile

    • Table Digene Corporation (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table AVIVA Biosciences Corporation (US) Company Profile

    • Table AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Laboratory Corporation of America Holdings (LabCorp) (US) Company Profile

    • Table Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table BIOVIEW Inc (US) Company Profile

    • Table BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US